NCT04653558

Brief Summary

In this retrospective cohort study of patients with early Lyme neuroborreliosis (LNB), clinical and microbiologic characteristics and long-term outcome of definite vs. possible LNB were evaluated at a single university medical center in Slovenia. Severity of acute disease and long-term outcome during a 12-month follow-up were assessed using a composite clinical score based on objective clinical findings and subjective complaints.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
311

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 4, 2020

Completed
Last Updated

December 7, 2020

Status Verified

December 1, 2020

Enrollment Period

10 years

First QC Date

November 28, 2020

Last Update Submit

December 3, 2020

Conditions

Keywords

Lyme neuroborreliosispost-Lyme borreliosis symptomsantibiotic therapy

Outcome Measures

Primary Outcomes (1)

  • composite clinical score

    Composite clinical score based on objective clinical findings and subjective complaints. The sum of subjective complaints and objective findings scored as 0=absent or 1=present represent severity of disease on admission or clinical outcome at follow-up, respectively. Maximum total score=31

    follow-up for 12 months-post-treatment

Study Arms (2)

definite LNB

patients with definite early Lyme neuroborreliosis

possible LNB

patients with possible early Lyme neuroborreliosis

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with definite or possible early Lyme neuroborreliosis

You may qualify if:

  • early Lyme neuroborreliosis

You may not qualify if:

  • Not fulfilling study criteria for definite or possible Lyme neuroborreliosis
  • Alternative diagnosis during follow-up
  • Concomitant tick-borne encephalitis
  • Clinical symptoms/signs present for \>6 months
  • Data not available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical center Ljubljana

Ljubljana, Slovenia

Location

MeSH Terms

Conditions

Lyme DiseaseLyme Neuroborreliosis

Condition Hierarchy (Ancestors)

Gram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsBorrelia InfectionsSpirochaetales InfectionsTick-Borne DiseasesVector Borne DiseasesCentral Nervous System Bacterial InfectionsCentral Nervous System InfectionsCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 28, 2020

First Posted

December 4, 2020

Study Start

January 1, 2008

Primary Completion

December 31, 2017

Study Completion

June 30, 2020

Last Updated

December 7, 2020

Record last verified: 2020-12

Locations